Tao Wen
- Pharmacology top 1%
- Cancer Research top 5%
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 14
- Heme Oxygenase-1 and Carbon Monoxide 9
- Epigenetics and DNA Methylation 7
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 13
- Galectins and Cancer Biology 13
- Immune Response and Inflammation 8
- Immune cells in cancer 7
-
- Liver Disease Diagnosis and Treatment 8
- Journals
- Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Tao Wen
110 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Pharmacology 332
- Cancer Research 542
- Molecular Biology 2.2k
- Immunology 647
- Complementary and alternative medicine 218
Countries citing papers authored by Tao Wen
This map shows the geographic impact of Tao Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Wen more than expected).
Fields of papers citing papers by Tao Wen
This network shows the impact of papers produced by Tao Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Wen. The network helps show where Tao Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 18 | |
| 10 | 2021 | 8 | |
| 11 | Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44 | 2020 | 2 |
| 12 | 2020 | 13 | |
| 13 | 2020 | 31 | |
| 14 | 2019 | 70 | |
| 15 | 2014 | 41 | |
| 16 | 2014 | 15 | |
| 17 | 2014 | 9 | |
| 18 | 2013 | 51 | |
| 19 | 2013 | 1 | |
| 20 | 2012 | 6 |
About Tao Wen
Tao Wen is a scholar working on Immunology, Hepatology and Cancer Research, having authored 114 papers that have together received 3.8k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (14 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers), Galectins and Cancer Biology (13 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Immune Response and Inflammation (8 papers), Epigenetics and DNA Methylation (7 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Pharmacology (332 citations), Cancer Research (542 citations) and Molecular Biology (2.2k citations). Tao Wen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiaoli Ru, Feng He, Jian Liu, Zongmei Wen, Zhao Jin-yuan, Li Guan, Xiuhui Li, Guangyu An, Yanlin Zhang and Lina Li. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.